Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Tau-Pathology in Parkinson's Disease Using [18F]PI-2620 and NeuroEXPLORER
NCT07020026Phase 2Recruiting
- Sponsor
- The Michael J. Fox Foundation for Parkinson's Research
- Start
- May 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 18F-PI-2620, sponsored by The Michael J. Fox Foundation for Parkinson's Research. Started May 2025; status: recruiting.
02
Drugs
18F-PI-2620
Beyond the preview
Go deeper on NCT07020026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07020026.